Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Rivista
Codice:
E061652
ISSN:
1354-3784
Dati Generali
Dati Generali
Pubblicazioni (13)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer
Articolo
Angiogenesis in biliary tract cancer: targeting and therapeutic potential
Articolo
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents
Articolo
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer
Articolo
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.
Articolo
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas.
Articolo
JAK inhibitors in crohn’s disease: ready to go?
Articolo
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials
Articolo
Nitric oxide: emerging concepts about its use in cell-based therapies
Articolo
Novel therapeutics in adult malignant brain gliomas
Articolo
PF-00547659 for the treatment of Crohn's disease and ulcerative colitis
Articolo
Phase I and phase II clinical trials for the treatment of male sexual dysfunction—a systematic review of the literature
Articolo
Why does survival of hepatocellular carcinoma patients remain so low? Key stumbling blocks and questions in preclinical and clinical development
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
